Hepatocellular carcinoma, renal cell carcinoma and differentiated thyroid carcinoma. research hub

An open-label, prospective, randomised, cross-over trial to assess the pharmacokinetics of an amorphous formulation of sorafenib in mesoporous magnesium carbonate (DPH001) compared to Nexavar® (sorafenib) in healthy volunteers

This study is testing a new way to give a cancer medicine called sorafenib, which is used for certain cancers like liver, kidney, and thyroid cancer. Researchers want to see how the new version works in healthy people compared to the current medicine.